ALHC vs. PRVA, HCSG, CYRX, CLOV, TARS, PCRX, GMTX, AKRO, SYRE, and VIR
Should you be buying Alignment Healthcare stock or one of its competitors? The main competitors of Alignment Healthcare include Privia Health Group (PRVA), Healthcare Services Group (HCSG), Cryoport (CYRX), Clover Health Investments (CLOV), Tarsus Pharmaceuticals (TARS), Pacira BioSciences (PCRX), Gemini Therapeutics (GMTX), Akero Therapeutics (AKRO), Spyre Therapeutics (SYRE), and Vir Biotechnology (VIR).
Privia Health Group (NASDAQ:PRVA) and Alignment Healthcare (NASDAQ:ALHC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, community ranking, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.
94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are held by institutional investors. 14.2% of Privia Health Group shares are held by company insiders. Comparatively, 6.6% of Alignment Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Privia Health Group has higher earnings, but lower revenue than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.
Privia Health Group has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.
Privia Health Group received 10 more outperform votes than Alignment Healthcare when rated by MarketBeat users. Likewise, 72.37% of users gave Privia Health Group an outperform vote while only 60.81% of users gave Alignment Healthcare an outperform vote.
Privia Health Group has a net margin of 1.11% compared to Privia Health Group's net margin of -7.81%. Alignment Healthcare's return on equity of 3.13% beat Privia Health Group's return on equity.
Privia Health Group presently has a consensus target price of $25.08, indicating a potential upside of 44.91%. Alignment Healthcare has a consensus target price of $8.69, indicating a potential upside of 21.43%. Given Alignment Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Privia Health Group is more favorable than Alignment Healthcare.
In the previous week, Privia Health Group had 10 more articles in the media than Alignment Healthcare. MarketBeat recorded 14 mentions for Privia Health Group and 4 mentions for Alignment Healthcare. Privia Health Group's average media sentiment score of 1.09 beat Alignment Healthcare's score of 0.90 indicating that Alignment Healthcare is being referred to more favorably in the news media.
Summary
Privia Health Group beats Alignment Healthcare on 15 of the 19 factors compared between the two stocks.
Get Alignment Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ALHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alignment Healthcare Competitors List
Related Companies and Tools
